The Relationship Between MAO Inhibition and Improvement of Depression: Preliminaiy Results with intravenous Modaline Sulfate (W3207B)
暂无分享,去创建一个
[1] D. F. Morgan,et al. INHIBITION OF MONOAMINE OXIDASE BY 2‐METHYL‐3‐PIPERIDINOPYRAZINE , 1963 .
[2] J. Gylys,et al. PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF 2‐METHYL‐3‐PIPERIDINOPYRAZINE, A NEW ANTIDEPRESSANT * , 1963, Annals of the New York Academy of Sciences.
[3] P. Feldman. COMPARISON OF EFFECT OF 2‐METHYL‐3‐PIPERIDINOPYRAZINE ON TARGET SYMPTOMS OF ANERGIC SCHIZOPHRENICS * , 1963, Annals of the New York Academy of Sciences.
[4] L. Goldstein,et al. QUANTITATIVE ELECTROENCEPHALOGRAPHY IN MAN AS A MEASURE OF CNS STIMULATION * , 1963 .
[5] E. Dunlop. ANTIDEPRESSANT EFFECTS OF MAO INHIBITORS * , 1963 .
[6] J. Pisano,et al. Determination of 3-methoxy-4-hydroxymandelic acid in urine. , 1962, Clinica chimica acta; international journal of clinical chemistry.
[7] Zeller Ea. Some remarks about monoamine oxidase and monoamine oxidase inhibitors. , 1961 .
[8] H. Hoagland,et al. An in vivo test for measuring monoamine oxidase inhibition in human subjects. , 1960, A.M.A. archives of general psychiatry.
[9] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[10] A. Pletscher. SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION FOR THE PHARMACOLOGICAL AND CLINICAL EFFECTS OF HYDRAZINE DERIVATIVES , 1959, Annals of the New York Academy of Sciences.
[11] O. Resnick. THE INFLUENCE OF AMINE OXIDASE INHIBITORS ON EPINEPHRINE METABOLISM IN MAN * , 1959, Annals of the New York Academy of Sciences.
[12] A. Voelkel. CLINICAL EXPERIENCES WITH AMINE OXIDASE INHIBITORS IN PSYCHIATRY , 1959 .
[13] A. Sjoerdsma,et al. Identification and assay of urinary tryptamine: application as an index of monoamine oxidase inhibition in man. , 1959, The Journal of pharmacology and experimental therapeutics.
[14] N. Kline,et al. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. , 1957, Psychiatric research reports.